Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
51.36
1.22 (2.43%)
At close: Aug 15, 2025, 12:32 PM

Anbio Biotechnology Class A Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023
Net Income
2.56M 4.68M 2.44M 1.64M
Depreciation & Amortization
n/a 3.54K 13.03K 9.49K
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-1.7M -1.21M -1.06M 394.13K
Other Non-Cash Items
-358.99K -306.78K -175.11K -17.68K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
48.33K -5.06M -1.3M 668.35K
Operating Cash Flow
2.25M -684.08K 971.71K 2.3M
Capital Expenditures
-1.36 -0.53 -0.28 0.56
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-38.39M -47.09M -20.06M n/a
Sales Maturities Of Investments
38.76M 47.4M 21.93M 1.71M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
364.91K 310.04K 1.87M 1.71M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
-373.04K 105.94K -46.33K -276.41K
Net Cash Flow
n/a n/a n/a n/a
Free Cash Flow
2.25M -684.08K 971.71K 2.3M